Somerset Group LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Somerset Group LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$360,000
-99.8%
1,660
-11.9%
0.27%
+19.8%
Q2 2020$231,327,000
+113295.6%
1,885
-3.5%
0.23%
+27.5%
Q4 2019$204,000
-79.6%
1,954
-77.5%
0.18%
-79.1%
Q3 2019$999,000
+10.3%
8,689
+65.4%
0.85%
+10.7%
Q2 2019$906,0005,2530.77%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 602,047$61,102,0006.76%
FT Options LLC 36,847$3,740,0005.64%
SCOPIA CAPITAL MANAGEMENT LP 2,988,019$303,254,0004.80%
FT Options LLC 71,000$1,320,0001.99%
Rock Springs Capital Management LP 373,000$37,856,0001.75%
Redmile Group, LLC 338,536$34,358,0001.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 362,724$36,813,0001.66%
Ghost Tree Capital, LLC 50,000$5,075,0001.08%
Atika Capital Management LLC 32,500$3,298,0000.95%
Sivik Global Healthcare LLC 25,000$2,537,0000.86%
View complete list of GW PHARMACEUTICALS PLC shareholders